Angitia Biopharmaceuticals
Signal active
Organization
Contact Information
Overview
Angitia Biopharmaceuticals is a global biotechnology company focusing on the discovery and development of innovative therapeutics for serious musculoskeletal diseases.
About
Industries
Biotechnology, Health Care, Medical, Biopharma
Founded
2018
Employees
101-250
Headquarters locations
Asia
Social
N/A
Profile Resume
Angitia Biopharmaceuticals headquartered in Asia, operates in the Biotechnology, Health Care, Medical, Biopharma sector. The company focuses on Biotechnology and has secured $10.0B in funding across 64 round(s). With a team of 101-250 employees, Angitia Biopharmaceuticals is actively contributing to advancements in Biotechnology. Their latest funding round, Series B - Angitia Biopharmaceuticals, raised $40.0M. Discover more about their projects, partnerships, and impact on our platform.
Employees
N/A
Funding Rounds
Funding rounds
4
Investors
1
Lead Investors
0
Total Funding Amount
$156.0M
Details
4
Angitia Biopharmaceuticals has raised a total of $156.0M in funding over 4 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2023 | Early Stage Venture | 46.0M | ||
| 2021 | Early Stage Venture | 70.0M | ||
| 2020 | Early Stage Venture | |||
| 2024 | Early Stage Venture | 40.0M |
Investors
Angitia Biopharmaceuticals is funded by 25 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Angitia Biopharmaceuticals | - | FUNDING ROUND - Angitia Biopharmaceuticals | undefined |
| Yonghua Capital | - | FUNDING ROUND - Yonghua Capital | undefined |
| Angitia Biopharmaceuticals | - | FUNDING ROUND - Angitia Biopharmaceuticals | 40.0M |
| Yuekai Securities | - | FUNDING ROUND - Yuekai Securities | 40.0M |
Recent Activity
There is no recent news or activity for this profile.